@article{c1c90b0bda3a46d2ae38d6be620dac8f,
title = "STEREOTACTIC RADIOSURGERY FOR MALIGNANT MELANOMA TO THE BRAIN",
author = "Seung, {Steven K.} and Shu, {Hui-Kuo G.} and McDermott, {Michael W.} and Sneed, {Penny K.} and Larson, {David A.}",
note = "The development of brain metastases from any primary cancer generally portends a very limited life expectancy. Without treatment, the median length of survival of patients with neurologic symptoms is about 1 month.36 Although pharmacologic therapies aimed at reducing cerebral edema often improve symptoms, these interventions have little impact on patient survival.24,46 The mainstay of treatment for patients with brain metastases has been fractionated radiation therapy since the first reports of its effectiveness.",
year = "1996",
month = dec,
day = "1",
doi = "10.1016/S0039-6109(05)70522-3",
language = "American English",
volume = "76",
journal = "Surgical Clinics of North America",
}